University of Colorado, Denver: Lung Neoplasms trials

The registry lists 22 Lung Neoplasms studies with University of Colorado, Denver as lead sponsor. 4 are open to participants now and 8 have results posted.

Phase 1 2Phase 2 7No phase 14(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Improving Care for Rural Patients With Solid TumorsRecruitingNCT04916990Not applicable
• Specimen Banking From Patients With Lung CancerRecruitingNCT01585675
• Molecular Analysis of Oncogenes and Resistance Mechanisms in Lung CancerRecruitingNCT01580982
• Biomarkers in Patients With Respiratory Tract Dysplasia or Lung Cancer, Head and Neck Cancer, or Aerodigestive Tract Cancer and in Normal VolunteersRecruitingNCT00900419
• Shared Decision Making in Rural Primary Care Lung Cancer Screening and Smoking CessationCompletedNCT04897568Not applicableResults posted
• Developing a Virtual Stress Management Intervention for Spousal/Partnered Caregivers of Solid Tumor Cancer Patients.Active, not recruitingNCT04739696Not applicableResults posted
• Brigatinib Before Brain Irradiation Trial (B3i Trial)TerminatedNCT04634110Phase 2Results posted
• Evaluating Crizotinib in the Neoadjuvant Setting in Patients With Non-small Cell Lung CancerCompletedNCT03088930Phase 2Results posted
• A Stepped Care Intervention to Reduce Disparities in Mental Health Services Among Cancer Patients and CaregiversCompletedNCT03016403Not applicableResults posted
• Feasibility Study Incorporating Lung Function Imaging Into Radiation Therapy for Lung Cancer PatientsCompletedNCT02528942Not applicableResults posted
• Study of Ponatinib in Patients With Lung Cancer Preselected Using Different Candidate Predictive BiomarkersCompletedNCT01935336Phase 2Results posted
• Iloprost in Preventing Lung Cancer in Patients at High Risk for This DiseaseCompletedNCT00084409Phase 2Results posted
• Testing the Engaged Approach to Lung Cancer ScreeningActive, not recruitingNCT06327074Not applicable
• Amivantamab With Tyrosine Kinase Inhibitors (TKI) for Advanced NSCLC With ALK, ROS1, or RET AlterationsActive, not recruitingNCT05845671Phase 1/2
• Detection of Resistance Mechanisms in Cerebrospinal Fluid for EGFR-mutant, ALK- and ROS1-rearrangedWithdrawnNCT05116618
• The Lung PCA: A Multi-Dimensional Atlas of Pulmonary PremalignancyActive, not recruitingNCT03881098Not applicable
• Pilot Study of High Risk Lung Cancer ScreeningCompletedNCT03683940Not applicable
• Pulmonary Physiology and Systemic Inflammatory in EO Pulmonary Events With Brigatinib Use in NSCLC and Other DiseasesCompletedNCT03389399
• Biomarkers in the Nose, Throat, and Lung Tissue of Smokers and Non-SmokersCompletedNCT00897364
• Phase I Study of Vorinostat and Sorafenib in Advanced CancerCompletedNCT00635791Phase 1
• Sputum Cytology in Screening Heavy Smokers For Lung CancerCompletedNCT00103363Phase 2
• 13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung CancerCompletedNCT00002586Phase 2